Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Volume 47 Issue 1, January 2026

Cover story: Artificial intelligence is revolutionizing ion channel drug discovery by tackling the inherent complexity and therapeutic significance of these intricate membrane proteins. Advanced algorithms are now unlocking the elusive GluN1/GluN3A receptor, enabling efficient exploration of expansive chemical spaces despite limited structural and ligand data—ultimately uncovering promising new modulators with high precision. Doi: 10.1038/s41401-025-01710-8.

Perspective

Top of page ⤴

Review Article

Top of page ⤴

Article

Top of page ⤴

Editorial Expression of Concern

Top of page ⤴

Search

Quick links